Clinical trial
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With…
NCT00003569 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003569 |
|---|---|
| Title | Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel |
| Official title | Phase I Trial of Escalating Doses of BNP7787 in Patients With Solid Tumors Undergoing Treatment With Cisplatin and Taxol |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Head and Neck Cancer, Lung Cancer, Neurotoxicity, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, dimesna, paclitaxel |
| Enrollment | 2 |
| Start date | Mar 1, 1998 |
| Primary completion | Jun 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: